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Bartonella bacilliformis, a hemotropic bacterium and the causative agent of the human disease bartonellosis,
when incubated in a tryptone-based medium produces an extracellular factor, termed deformation factor (DF),
which induces extensive indentations and trenches in trypsinized erythrocyte membranes. The factor is stable
during storage at 4°C. It can be inactivated by proteases or brief heating to 70 to 80°C, can be precipitated by
ammonium sulfate, is nondialyzable, and is retained by membranes with a 30,000-molecular-weight cutoff.
These properties suggest that DF is probably a protein. Incubation of erythrocytes with phospholipase D
renders them resistant to deformation by DF.
Bartonella bacilliformis is an interesting and unique bac-
terial pathogen which causes bartonellosis (Carrion's dis-
ease) in humans. Transmission occurs through the bite of a
sandfly which is indigenous to remote valleys on the western
slopes of the Andes in Columbia, Ecuador, and Peru (13).
Because of its restricted geographic distribution, bartonello-
sis has received only sporadic research attention outside
Peru. However, it remains a health problem in its endemic
area, as indicated by a recent epidemic in the Peruvian
Andes in which 14 patients died and another 14 were
seriously affected (9). Humans are the only known natural
reservoir for B. bacilliformis, which suggests the possibility
of eradicating the disease.
Both erythrocytes and vascular endothelial cells are para-
sitized in vivo by these highly motile hemotropic bacteria.
Tropism for these cell types gives rise to the distinct hematic
(Oroya fever) and tissue (verruga peruana) phases of the
disease (13). The acute anemia of Oroya fever, during which
100% of the erythrocytes may become infected, is in some
respects analogous to that of malaria, where premature
destruction of parasitized erythrocytes occurs. It has been
suggested that bartonella-parasitized cells are selectively
phagocytized by cells of the reticuloendothelial system
which recognizes them as altered (16), thus accounting for
the dramatic decrease in erythrocyte number.
The tissue (verruga) stage of bartonellosis is characterized
by hemangiomatous dermal eruptions resulting from marked
endothelial cell proliferation. These lesions are reported to
be strikingly similar both clinically and histologically to
those of bacillary (epithelioid) angiomatosis, a recently rec-
ognized bacterial complication seen in AIDS patients (3).
Garcia et al. (7) have recently shown that B. bacilliformis
synthesizes a protein which stimulates endothelial cell pro-
liferation in an in vitro system and also proliferation of new
blood vessels in an in vivo model for angiogenesis, support-
ing an earlier suggestion by Arias-Stella et al. (1) that B.
bacilliformis possesses angiogenic potential.
In vitro, the bacteria adhere to and gain entry into eryth-
rocytes, initially enclosed within intracellular vacuoles (2, 4,
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15). (B. bacilliformis has also been shown to enter cultured
nucleated mammalian cells [11], as has Escherichia coli
containing a cloned 6.2-kDa fragment of B. bacilliformis
DNA [12]). The in vitro interaction of B. bacillifonnis with
erythrocytes is accompanied by a dramatic, yet reversible,
deformation of the cell surface with prominent pits,
trenches, and invaginations (2). In vivo, B. bacilliformis may
employ a similar mechanism of entry, since the bacteria have
been detected in vacuolelike structures in erythrocytes from
clinically infected patients (5). Anaplasma marginale, a
hemotropic bacterium of veterinary importance which is
related to Bartonella spp., is also known to attach to
erythrocytes and to induce membrane invagination at the
point of attachment which culminates in the formation of
parasitic vacuoles (6, 14).
Erythrocytes are an exceptionally suitable host for the
study of intracellular parasitism, since they are markedly
nonendocytic. The finding of B. bacilliformis contained
within vacuolelike structures indicates that the bacteria must
initiate and mediate the process leading to their uptake by
the erythrocytes. Formation of deep invaginations seen
during entry is probably aided by mechanical forces gener-
ated by the highly motile bacteria, but in this report, we
show that an extracellular bacterial product, termed defor-
mation factor (DF), can produce extensive morphological
changes in the erythrocyte surface independently of the
bacteria.
MATERIALS AND METHODS
Strains and growth. B. bacillifonnis was originally ob-
tained from H. H. Winkler (Department of Microbiology and
Immunology, University of South Alabama School of Med-
icine, Mobile, Ala.). Stock cultures were stored at -70°C
with dimethyl sulfoxide added to a final concentration of
10%. For growth, frozen cultures were rapidly thawed in a
37°C water bath and transferred to brain heart infusion agar
(BBL, Cockeysville, Md.) containing 10% (vol/vol) human
serum (GIBCO Laboratories/BRL, Grand Island, N.Y.) and
10% (vol/vol) human erythrocyte lysate prepared as de-
scribed by Benson et al. (2) from outdated blood bank
erythrocytes (American Red Cross, Waco, Tex.). A 2.5- to
3-ml overlay of phosphate-buffered saline (PBS) (8 mM
Na2HPO4, 1 mM KH2PO4, 3 mM KCl, 117 mM NaCl, pH
937
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7.4) was then added to each plate, and the cultures were
incubated at 30°C. This overlay was used as an inoculum for
incubation in liquid media. All assays were performed with
cultures in exponential growth.
Deformation and entry assays. Bacterially induced eryth-
rocyte deformation was assessed by incubating bacteria and
erythrocytes at 30 to 35°C in modified Geiman's medium (8).
Assays were carried out in petri dishes (35 by 10 mm). In a
typical assay, 200 ,ul of a log-phase culture (-2 x 108
bacteria) of B. bacilliformis was mixed with 50 ,ul of a 50%
erythrocyte suspension in 1 ml of medium containing, in final
concentration, 1% autoclaved tryptone broth (Difco, De-
troit, Mich.), pH 7.8; 0.5% NaCl; and filtered supplements of
0.5% human serum albumin (wt/vol) (Sigma Chemical Co.,
St. Louis, Mo.), 10 mM glucose, 5 mM inosine, and 0.2%
(vol/vol) of a lOx amino acid-ascorbic acid-glutathione so-
lution. After incubation, erythrocyte deformation was deter-
mined microscopically with a Zeiss microscope equipped
with Nomarski optics. Cells scored as positive either had
visible bacteria rotating on their surfaces or were extensively
scarred with prominent pits, trenches, or invaginations. Two
to three hundred cells were routinely counted. Entry of B.
bacilliformis into erythrocytes was determined after 24 h by
incubating washed cells with ethidium bromide (200 ,ug of
PBS per ml, pH 7.4) for 45 min in a 37°C water bath. After
incubation, cells were pelleted, washed, and observed by
fluorescent microscopy. Ethidium bromide intercalates into
DNA, and, since mature erythrocytes are anucleated, fluo-
rescent intracellular bacteria were easily detected micro-
scopically.
Erythrocyte deformation was also studied by using cell-
free filtrates. Filtrates were prepared by removal of bacteria
with 0.2-pum-pore-size filters (Amicon, Beverly, Mass.) from
tryptone-based medium which had been inoculated at a 1:5
(vol/vol) ratio (about 2 x 108 bacteria per ml) with PBS
overlays from overnight agar plate culture and grown for 2.5
to 3 h at 35°C. Control filtrates were prepared in a similar
manner except that the overlays containing bacteria were
replaced with sterile PBS overlays incubated overnight on
agar plates.
Erythrocytes. Erythrocytes were collected from human
volunteers by venipuncture into heparinized Vacutainer
tubes. The cells were pelleted by centrifugation, washed
three times, and resuspended to 50% packed cell volume in
PBS, pH 7.4, containing 10 mM glucose and 5 mM inosine.
Refrigerated cell suspensions could be used for approxi-
mately 2 weeks. If cells were washed weekly and resus-
pended in fresh PBS-glucose-inosine, they could be used for
at least a month.
For experiments involving enzymatically treated cells, the
erythrocytes were diluted to -2 x 10 cells per ml in
PBS-glucose-inosine and incubated for 30 min in a 37°C
water bath with an equal volume of PBS or enzyme. A 10-ml
volume of PBS-glucose-inosine was then added, and the
cells were pelleted by centrifugation. After three additional
washes, the cell pellet was resuspended in 250 p.l of PBS-
glucose-inosine. Cells prepared in this manner were subse-
quently exposed to either B. bacilliformis or sterile PBS
overlay after being mixed with tryptone medium. For exper-
iments using bacterial or control filtrates, a 50% erythrocyte
suspension was mixed 1:1 (vol/vol) with tolylsulfonyl phe-
nylalanyl chloromethyl ketone (TPCK)-trypsin (1 mg/ml of
PBS), incubated, and washed as described previously and
then resuspended to its original volume with PBS-glucose-
inosine. These cells were subsequently incubated with fil-
trates at a 1:20 (vol/vol) ratio.
TPCK-trypsin (Worthington Biochemicals, Freehold,
N.J.) and trypsin type XI from bovine pancreas (Sigma)
were both used with equal effectiveness to sensitize eryth-
rocytes to DF. These enzymes were used at a concentration
of 1 mg/ml in PBS, pH 7.2, unless otherwise indicated. All
additional enzymes were obtained from Sigma and used at
the concentrations indicated. Those used included cx-chy-
motrypsin type VII derived from bovine pancreas (500 p.g/ml
of PBS); Clostridium perfringens neuraminidase type V (1
U/ml of PBS, pH 7.2, containing 1 mM CaCl2); phospholi-
pase A2 from bovine pancreas (500 p.g/ml of PBS); phospho-
lipase B from Vbrio species (500 p.g/ml of PBS); phospholi-
pase C type I (lecithinase) from Clostridium welchii (200
,ug/ml of PBS); and phospholipase D types I, IV, and V from
cabbage, type II from peanut, type VI from Streptomyces
chromofiuscus, and type VII from Streptomyces species (500
,ug/ml of PBS). All phospholipases, with the exception of
phospholipase C, were used at a concentration of 500 p.g/ml.
Phospholipase C was diluted to 200 p.g/ml.
RESULTS
Kinetics of the interaction of B. baciliformis with erythro-
cytes. Erythrocytes incubated with motile, log-phase B.
bacilliformis became extensively deformed, beginning be-
tween 1 and 2 h after mixing (Fig. 1A). Erythrocytes
incubated without B. bacilliformis or separated from the
bacteria by a dialysis membrane retained their normal mor-
phology (Fig. 1B). The percentage of cells deformed, as well
as the degree of deformation, reached maximum levels after
about 6 h (Fig. 2). Cell deformation was reversible since,
after prolonged incubation (24 h), relatively few deformed
cells were observed. Deformation did not require the con-
tinued presence of bacteria bound to the cells, and in fact
most of the deformed cells had no bacteria on their surfaces.
Entry of bacteria into erythrocytes lagged behind deforma-
tion by 2 to 4 h (Fig. 2), indicating that the process leading to
deformation precedes entry and may be a prerequisite for
entry. Although levels of deformation frequently reached
50% or more, only 10 to 20% of the erythrocytes ultimately
contained intracellular bacteria, further indicating that de-
formation is not a consequence of entry. When the number
of bacteria added per erythrocyte was increased, more
deformed cells were seen, but the number of cells with
intracellular bacteria decreased, apparently because of de-
creased bacterial motility at higher bacterial concentrations
(data not shown).
Effect of temperature and pH. Temperatures of 28 to 37°C
were optimum for deformation and entry (Table 1). Below 24
or above 40°C, little or no deformation occurred. Entry of B.
bacillifonnis appeared to be more sensitive to low tempera-
tures than deformation; for example, in one experiment,
when plates were held at 20°C throughout the incubation
period, a 3-fold decrease in deformation and a 30-fold
reduction in entry were observed. The effect of low-temper-
ature inhibition was reversible, and normal levels of eryth-
rocyte deformation and entry were observed following trans-
fer of plates from a 6-h low-temperature preincubation to
30°C. If plates were first incubated for 4 h at 30°C and then
placed at 4°C, a significant (fivefold) reduction in entry was
seen, although the inhibitory effect of low temperatures was
most pronounced when plates were transferred to the lower
temperatures within the first 3 h of incubation. No deforma-
tion or entry occurred with continuous incubation at 4°C.
The absence of deformation and entry above 40°C was most
likely due to a direct, deleterious effect of the high temper-
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FIG. 1. B. bacilliformis-induced deformation of human erythrocytes. Nontrypsinized erythrocytes after 5 h of incubation with B.
bacillifonnis (A) or sterile PBS overlay (B). Trypsinized cells after 5 h of incubation with a B. bacilliformis filtrate (C) or uninoculated,
incubated filtrate (D).
ature on the bacteria, since the inhibitory effect was not
reversible when the temperature was lowered.
A pronounced pH effect was also noted. Deformation and
entry were maximal at about pH 7.4 and considerably
reduced at pH values of 6 and 8 (Table 1).
Effect of enzymatic modification of erythrocytes. Treatment
of erythrocytes with trypsin or neuraminidase prior to incu-
bation with B. bacilliformis greatly increased the extent
of deformation and entry (Table 2). The effect of trypsin
was concentration dependent, since lower percentages of
erythrocytes were deformed with decreasing trypsin con-
centrations. In one experiment, 96% of erythrocytes pre-
treated with 1 mg/ml were deformed and 86% were deformed
at 0.1 jig/ml, as compared with 34% for untrypsinized
erythrocytes. Trypsin alone at 1 mg/ml generally caused
<5% erythrocyte deformation, an insignificant amount.
Trypsinization of the bacteria, followed by removal of the
enzyme by centrifugation and washing, did not affect defor-
mation or entry, a result consistent with the view that
enhanced deformation was due to an enzyme-dependent
change in the erythrocyte membrane.
In contrast to the effect of trypsin, specific phospholipases
significantly reduced deformation and abolished entry. Incu-
bation of erythrocytes with phospholipase D type VI for 5,
30, and 60 min reduced deformation to 20, 5, and 3%,
respectively, of control values. Importantly, cells treated for
only 5 min with the enzyme were completely refractory to
entry. If phospholipase D was added to bacteria and eryth-
rocytes being incubated together after deformation was well
under way (-3 h), the phospholipase produced little effect.
In this experiment the bacteria retained their motility
throughout the observation period, so the enzyme's effect is
unlikely to be bactericidal in nature. Of several phospholi-
pase enzymes tested, only those phospholipase D types
derived from Streptomyces species were effective.
Effect of chemical and physical agents. Erythrocytes ex-
posed to 0.032% glutaraldehyde for 5 min were completely
refractory to deformation and entry, indicating that the
bacteria are unable to deform or enter erythrocytes whose
membranes are rendered more rigid by cross-linking.
Pre-treatment of B. bacilliformis for 30 min with various
chemical and physical agents, such as heat (52 or 100°C), 50
mM NaN3, or 3% formaldehyde, which killed the bacteria,
abolished their ability to deform erythrocytes. Continuous
presence of 1 mM KCN or 50 mM NaF inhibited deforma-
tion as measured at 6 h, but if the bacteria were washed
following treatment, neither inhibited deformation. KCN
added at 6 h did not reverse the deformation which had
already occurred (Table 3).
Pretreatment of B. bacilliformis with normal rabbit, horse,
or human serum or with anti-B. bacilliformis rabbit serum
prevented both deformation and entry. Fetal bovine serum
I
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FIG. 2. Time course of B. bacillifornis-induced erythrocyte de-
formation (L) and entry (A). Culture fluid (200 ,ul) was incubated
with 50 pl of erythrocytes in 1 ml of tryptone medium at 30°C. A
total of 300 cells was counted at each time point.
was less inhibitory, with deformation and entry reduced by
only 40 and 30%, respectively. Microscopic examination of
serum-treated B. bacilliformis showed large aggregates of
bacteria which were either slowly motile or nonmotile.
Neither dialysis nor extraction of human serum with chloro-
form (1:5 vol/vol) removed its inhibitory activity. Dilution of
the sera resulted in loss of inhibitory activity.
Deformation appears not to be a consequence of mechan-
ical distortion of the erythrocyte membrane by motile bac-
teria since nonmotile B. bacilliformis could also induce
erythrocyte deformation, although at much lower levels.
However, nonmotile bacteria never gained entry into the
cells. This observation indicates that binding, deformation,
and the requirement for motility are separable but related
TABLE 1. Effect of temperature and pH on B. bacilliformis-
induced erythrocyte deformationa
% of erythrocytes:
Temp (°C)
or pH Showing With intracellular
deformation bacteria
Temp
4 0 0
15 0 0
21 0 0
23 0 5
28 41 13
30 41 15
37 37 20
40 30 7
43 8 1
pH
6 6 1.5
7 12 5
7.4 27 8
7.8 20 7
8 3 6
a Cells were scored for deformation after 6 h of incubation and for
intracellular bacteria after 24 h.
TABLE 2. Effect of enzymatic modification of erythrocytes
on B. bacilliformis-induced deformation
Erythrocytes with Erythrocytes with
B. bacilliformis B. bacillifornisErythrocyte treatment flrt% Defor- % filtrate
mation Entry (% deformation)
Treatment 1a
PBS 38 20
Trypsin (1 mg/ml) 98 32
Neuraminidase (1 U/ml) 75 22
Phospholipase A2 (500 ,ug/ml) 43 22
Phospholipase B (500 ,ug/ml) 50 22
Phospholipase C (200 ,ug/ml) b __b
Phospholipase D type VI 3 0.6
(500 ,ug/ml)
Treatment 2a
PBS 51 15
Phospholipase D type I 49 16
(500 p.g/ml)
Phospholipase D type II 50 16
(500 ,ug/ml)
Phospholipase D type IV 47 16
(500 ,ug/ml)
Phospholipase D type V 48 17
(500 pg/ml)
Phospholipase D type VI 6 2
(500 pg/ml)
Phospholipase D type VII 6 0.2
(500 iig/ml)
Treatment 3C
PBS 46 0.6
PBS/PBS 47 1.3
Trypsin (1,000 pLg/ml) 95 44
Phospholipase D type VI 3 0.8
(500 ,ug/ml)
Trypsin and phospholipase D 26 4
type VI
a Erythrocytes were incubated with PBS or enzymes for 30 min at 37°C,
washed, resuspended, and mixed with B. bacillifornis. Erythrocytes were
scored for deformation after 5 h and entry after 24 h.b_, cells lysed.
c Erythrocytes were incubated either singly or sequentially with PBS and
enzymes as described above. Cells were mixed with B. bacilliformnis or with B.
bacilliformis filtrate and scored for deformation after 5 h.
aspects of entry, and it suggests that deformation might be
the result of a biochemical factor rather than a purely
mechanical event.
DF. When B. bacilliformis was incubated in tryptone-
based medium and then removed by filtration, the filtrate
was found to contain a factor which could deform erythro-
cytes which had been pretreated with trypsin at 1 mg/ml.
Subsequent experiments by You-Han Xu (17) demonstrated
that neuraminidase could also sensitize the cells to DF. The
appearance of these deformed erythrocytes was identical to
that of erythrocytes which had been incubated with B.
bacilliformis (Fig. 1A and C). Deformation was time depen-
dent, and a short lag was observed before significant defor-
mation was observed (Fig. 3). At the concentrations used,
deformation was not seen with untrypsinized red cells,
although subsequent experiments by You-Han Xu (17) have
shown the untrypsinized cells can be deformed by high
concentrations of DF. Deformation was not observed when
filtrates of uninoculated growth medium were used (Fig. 1D).
When B. bacilliformis were incubated in sterile tryptone-
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TABLE 3. Effect of KCN and kanamycin on B. bacilliformis-
induced erythrocyte deformationa
% Inhibition" with:
Time of KCN Kanamycin
addition (h) Deformation
Deformation Entry Deformation Entry by filtrate
0 100 56 100 100 81
1 35
2 96 70 95 96 8
3 8
4 46 64 42 64
6 0 0 12 26
8 0 0
a One hundred microliters of 1 mM KCN or PBS or 250 Ill of kanamycin (10
mg/ml) or PBS was added to a suspension of bacteria and erythrocytes at zero
time or after incubation. Cells were scored for deformation at 6 h (KCN) or 8
h (kanamycin) and for intracellular bacteria at 24 h. For filtrates, kanamycin
or PBS was added at the indicated times after mixing B. bacilliformis culture
fluid and tryptone medium. Incubation was continued for a total of 3 h, and the
bacteria were removed by filtration. DF activity in the filtrate was determined
by incubating with trypsinized cells for 5 h. The three experiments were
conducted separately.
b Percent inhibition was calculated as [(activity of PBS control - activity of
KCN or kanamycin)/activity of PBS control] x 100.
based medium, deforming activity increased in a time-
dependent manner and required approximately 2 h of incu-
bation to reach its maximum value. Only low levels of
activity were present in filtrates prepared directly from
cultures. Since no deforming activity was observed with
bacteria incubated with brain heart infusion, RPMI, or PBS
supplemented with human serum albumin and NaCI, it is
likely that tryptone provides some nutrient essential for
induction or synthesis of the DF. If the medium was diluted
with PBS, the number of deformed erythrocytes decreased
significantly, suggesting that some medium component re-
quired for DF synthesis or excretion became limiting. It is,
however, possible that dilution simply slowed the bacterial
metabolism, although the bacteria remained motile for 4 to 6
h. If the tryptone concentration was increased, more cells
were deformed after 1 h and the maximum level of erythro-
cyte deformation was reached much earlier. Dialysis or
heating of the tryptone-based medium for 2 min at 90°C or
100°C prior to the addition of bacteria greatly reduced or
abolished deforming activity. Heating presumably affected
the supplements, probably the human serum albumin frac-
tion, since the tryptone had previously been autoclaved.
Kanamycin completely inhibited B. bacilliformis-induced
deformation and entry if added when bacteria and erythro-
cytes were mixed and was less effective if the addition of
kanamycin was delayed until after 2 h (Table 3). Addition of
kanamycin to bacteria incubating in tryptone medium elim-
inated deformation activity in the filtrate prepared from the
incubation mixture. Kanamycin added during the first 2 h of
incubation markedly decreased deforming activity when the
filtrates were subsequently assayed directly for deforming
activity, suggesting that DF is synthesized during this pe-
riod. Even when erythrocytes were incubated directly with
DF, a period of time was required before deformation was
seen. This lag period was generally shorter than that ob-
served when bacteria were used, possibly in part because of
the time required for synthesis or export of DF by whole
bacteria. When untrypsinized erythrocytes and bacteria
were incubated, addition of DF did not shorten the lag
period, presumably because DF is relatively ineffective on
0
-g 50
O 40-
o 30
m: 20-
10-
0
0 1 2 3 4 5 6
Time (hrs)
FIG. 3. Time-dependent deformation of trypsinized erythrocytes
(RBCs) by a filtrate of medium in which B. bacilliformis was
incubated. The filtrate was mixed with trypsinized erythrocytes, and
the mixture was incubated at 350C. Cells were scored for deforma-
tion at each time point. Trypsinized erythrocytes incubated with a
similar filtrate from uninoculated medium were not deformed.
untrypsinized erythrocytes. This suggests that the bacteria
may cause some change in the erythrocyte membrane to
render it more sensitive to DF.
Properties of DF. Filtrates containing DF could be stored
for at least 2 weeks at 0, -20, or -70°C without loss of
activity, and repeated freezing (-70°C) and thawing (37°C)
did not alter the level of activity. DF could be inactivated by
heating 1-ml volumes of filtrate for 2 min prior to mixing with
trypsinized erythrocyte and subsequent incubation for 5 h at
35°C. As shown in Fig. 4, deforming activity was destroyed
between 70 and 80°C. DF activity could also be depleted
from filtrates by sequential incubation with batches of
trypsinized erythrocytes, suggesting the possibility that DF
binds directly to the erythrocytes. After two rounds of
incubation with erythrocytes, deforming activity was re-
duced by 30%, and after three rounds, it was decreased by
70%.
DF could be precipitated from filtrates with saturated
(NH4)2SO4 at a final concentration of 60% (vol/vol), suggest-
ing that it may be a protein or possibly a compound bound to
a protein. Precipitates from both bacterial and control fil-
trates were collected by centrifugation, resuspended to 10%
of the original volume in PBS, and dialyzed. For assay, the
solubilized precipitates were mixed with tryptone medium
(1:10, vol/vol) and trypsinized erythrocytes.
All of the deforming activity in filtrates was retained by an
Amicon Centriprep 30 membrane, suggesting a molecular
weight greater than 30,000. Filtrates were centrifuged for 30
min at 300 x g, after which both filtrates and retentates were
tested for deforming activity by mixing with trypsinized
erythrocytes and incubating 5 h at 35°C. The activity of DF
in filtrates was sensitive to proteases such as oa-chymo-
trypsin which, at final concentrations of 500 ,ug/ml, reduced
deforming activity to approximately 5% of the control value.
Treatment of either normal or trypsinized erythrocytes
with phospholipase D type VI greatly reduced the cells'
capacity for deformation by live bacteria or by filtrate (Table
2). This suggests that the erythrocyte target for DF is
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FIG. 4. Effect of temperature on deforming activity of filtrates.
B. bacillifonnis filtrates were heated for 2 min at various tempera-
tures and mixed with trypsinized erythrocytes (RBCs), and the
mixture was incubated at 35°C. After 5 h, cells were scored for
deformation. Trypsinized erythrocytes incubated with a filtrate from
uninoculated medium heated correspondingly showed no deforma-
tion.
disrupted by the action of phospholipase D and that the
factor produced by B. bacilliformis during incubation with
erythrocytes and the factor present in filtrates have a similar
target.
DISCUSSION
Experiments reported here demonstrate the existence of
an extracellular factor produced by B. bacilliformis, termed
DF. This factor deforms trypsinized erythrocytes and repro-
duces the morphological changes seen in erythrocytes incu-
bated with live bacteria during the invasive process, leading
to intracellular parasitism of these cells.
When B. bacilliformis was added to erythrocytes, revers-
ible binding of bacteria to the erythrocytes was observed.
Actual attachments clearly occurred, as opposed to transient
collisions, since the erythrocytes' visibility rotated in re-
sponse to the attached motile bacterium. However, the
association frequently was observed to terminate with an
abrupt separation of the two. No deformation or invagina-
tion or other residual evidence of binding was visible in this
case. Binding can therefore occur in the absence of visible
deformation. A few deformed erythrocytes could be seen
after about an hour of incubation, and the frequency in-
creased as the incubation was continued, so that after about
6 h extensive deformation and invagination of the erythro-
cytes were seen. Some deformed erythrocytes with bound
bacteria could be observed (and subsequently bacteria in
internal vacuoles were found), but most erythrocytes, al-
though deformed and similar in appearance, were free of
bound bacteria. This observation shows that maintenance of
the deformed state does not require the continuous presence
of bound bacteria and suggested that binding of bacteria
might not be necessary for deformation to occur.
The 'physical and chemical characteristics of DF are
consistent with its being a protein. DF was stable during
storage at 4°C or after freezing and was not inactivated by
several cycles of freezing and thawing. DF could be inacti-
vated by heating to 70 to 80°C. It could be precipitated by
ammonium sulfate, was nondialyzable, and was retained by
a membrane with a 30,000-molecular-weight cutoff. It could
be inactivated by proteases, and its synthesis could be
prevented by antibiotics such as kanamycin or by metabolic
inhibitors. The lag period observed after bacteria were added
to erythrocytes and before maximal deformation occurred
may be accounted for largely by the time required for
synthesis and/or export of DF; however, there was also a lag
after addition of DF to trypsinized erythrocytes before
deformation was observed. After removal of the bacteria by
centrifugation, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis of the supernatant demonstrated the pres-
ence of several distinct polypeptides synthesized by B.
bacilliformis, including major polypeptides with molecular
weights of 66,000 and 38,000 and smaller quantities of other
polypeptides of bacterial origin (17). A recent study by
Knobloch and Schreiber (10) has identified a 65,000-dalton
protein as one of the major antigens of B. bacilliformis.
Incubation of erythrocytes with phospholipase D renders
them resistant to deformation by DF. The phospholipase
D-sensitive membrane component has not yet been identi-
fied. Possibly the action of phospholipase D modifies mem-
brane deformability, as does glutaraldehyde treatment,
which abolishes the capacity for deformation and entry of B.
bacillifonnis. It is more likely, however, that either phos-
pholipase D modifies a substrate for DF or inactivates a
receptor for DF. There is some evidence that DF binds to
erythrocytes, since activity is lost from the supernatant after
serial addition and removal of erythrocytes.
Binding of B. bacilliformis is in some manner related to
DF, perhaps indirectly, since treatment of the erythrocytes
with phospholipase D affects both the ability of the bacteria
to bind to the erythrocytes and the ability of DF to deform
the erythrocytes. Bacteria bound after deformation begins
appear to be more tightly bound and to dissociate less readily
than bacteria bound before deformation commences. Possi-
bly, bacteria simply have difficulty in withdrawing from deep
invaginations as seen by Benson et al. (2); alternately, DF
may be present both as an extracellular factor and on the
surface of the bacteria, where it may assist in binding the
bacteria to the erythrocyte membrane. Bacterial motility
seems to be required for internalization, since entry of
nonmotile B. bacilliformis centrifuged onto erythrocytes was
not observed. Deep invaginations which conform approxi-
mately to the dimensions of the bacteria were previously
seen by scanning electron microscopy (2) and may be the
result of mechanical pressure applied to a erythrocyte mem-
brane rendered more deformable by DF.
DF requires prior modification of the erythrocyte surface
with trypsin to produce a significant effect. Entry of B.
bacilliformis, much more so than binding, is facilitated by
treatment of the erythrocytes with trypsin or neuraminidase.
This suggests that removal of proteins, or possibly nega-
tively charged sialic acid residues associated with proteins
such as glycophorin on the erythrocyte surface, facilitates
binding of DF or its ability to deform the membrane.
Although trypsin-dependent sensitization of erythrocyte
membranes to DF suggests that a bacterial trypsinlike or
neuraminidaselike activity may be involved in entry, there is
not enough sensitizing activity present in the filtrate to
permit the erythrocytes to be extensively deformed by DF
without the addition of trypsin. If such an extracellular
activity exists, possibly it was inactivated, or possibly it is a
surface component of B. bacilliformis.
Experiments to identify DF with a B. bacilliformis protein
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and to clone the gene responsible for deformation activity
are currently in progress, as are studies to identify the
putative receptor or substrate for DF defined by phospholi-
pase D sensitivity.
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